Websites Selling Compounded GLP-1 RAs Often Misinform Consumers
Only 34 of 79 websites stated that compounded drugs were not FDA approved; 39 websites did not report adverse effects, warnings
1999 to 2021 Saw Rise in Methamphetamine-Related Mortality
This trend may be driven by increases in heroin and synthetic opioids coinvolvement
Moderna Receives $590M From HHS to Develop Bird Flu Vaccine
Antipsychotics at Doses >75 mg a Day Linked to Risk for Tardive Dyskinesia
Significantly increased risk for tardive dyskinesia seen with doses >75 mg/day at last prescription and as maximum dose
Adjuvant Trastuzumab Emtansine Improves Overall Survival in HER2+ Breast Cancer
T-DM1 sustained the improvement in invasive disease-free survival over trastuzumab in HER2-positive early breast cancer
ACIP Immunization Schedules Issued for Children, Adults
Changes to both schedules include new and updated recommendations for COVID-19 vaccine, change to trivalent influenza vaccines
FDA Approves Omvoh for Moderately to Severely Active Crohn Disease
Approval based on results from phase 3 VIVID-1 trial, in which end points of clinical remission and endoscopic response were met at one year
Zoledronate Prevents Morphometric Vertebral Fractures Over 10 Years
Zoledronate administered at baseline and five years effective for preventing fragility fracture, any fracture, major osteoporotic fracture
Glucarpidase Improves Outcomes in Patients With Methotrexate-Induced Kidney Toxicity
Glucarpidase associated with 2.70-fold increased odds of kidney recovery in methotrexate-acute kidney injury
TACE + Lenvatinib, Pembrolizumab Tied to Improved Survival in Unresectable Liver Cancer
Clinically meaningful improvement seen in progression-free survival for transarterial chemoembolization plus lenvatinib and pembrolizumab
